• Wiley Online Library will be disrupted on 18 May from 10:00-12:00 BST (05:00-07:00 EDT) for essential maintenance

Special Article

You have full text access to this OnlineOpen article

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features†‡§‖††

  1. Timothy Beukelman1,*,
  2. Nivedita M. Patkar1,
  3. Kenneth G. Saag1,‡‡,
  4. Sue Tolleson-Rinehart2,
  5. Randy Q. Cron1,
  6. Esi Morgan DeWitt3,
  7. Norman T. Ilowite4,§§,
  8. Yukiko Kimura5,¶¶,
  9. Ronald M. Laxer6,‖‖,
  10. Daniel J. Lovell3,
  11. Alberto Martini7,†††,
  12. C. Egla Rabinovich8,
  13. Nicolino Ruperto7,‡‡‡

Article first published online: 30 MAR 2011

DOI: 10.1002/acr.20460

Issue

Arthritis Care & Research

Arthritis Care & Research

Volume 63, Issue 4, pages 465–482, April 2011

Additional Information

How to Cite

Beukelman, T., Patkar, N. M., Saag, K. G., Tolleson-Rinehart, S., Cron, R. Q., DeWitt, E. M., Ilowite, N. T., Kimura, Y., Laxer, R. M., Lovell, D. J., Martini, A., Rabinovich, C. E. and Ruperto, N. (2011), 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res, 63: 465–482. doi: 10.1002/acr.20460

Author Information

  1. 1

    University of Alabama at Birmingham

  2. 2

    University of North Carolina at Chapel Hill

  3. 3

    Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

  4. 4

    Children's Hospital at Montefiore, Bronx, New York

  5. 5

    Sanzari Children's Hospital at Hackensack University Medical Center, Hackensack, New Jersey

  6. 6

    University of Toronto and Hospital for Sick Children, Toronto, Ontario, Canada

  7. 7

    IRCCS Istituto G. Gaslini and University of Genoa, Pediatria II, Reumatologia, Genoa, Italy

  8. 8

    Duke University, Durham, North Carolina

  1. ‡‡

    Dr. Saag has received consultant fees, speaking fees, and/or honoraria (less than $10,000 each) from Merck, Lilly, Novartis, P&G, Aventis, Genentech, Takeda, AstraZeneca, and Horizon.

  2. §§

    Dr. Ilowite has received consultant fees, speaking fees, and/or honoraria (less than $10,000) from Genentech.

  3. ¶¶

    Dr. Kimura has served on the advisory board for Genentech and received a fee (less than $10,000).

  4. ‖‖

    Dr. Laxer is the Chair of the advisory board for Novartis and receives a fee (less than $10,000).

  5. †††

    Dr. Martini has received consultant fees, speaking fees, and/or honoraria (less than $10,000) from Bristol-Myers Squibb.

  6. ‡‡‡

    Dr. Ruperto has received consultant fees, speaking fees, and/or honoraria (less than $10,000 each) from Bristol-Myers Squibb, Roche, and Novartis.

*Pediatric Rheumatology, University of Alabama at Birmingham, 1600 7th Avenue South CPP 210, Birmingham, AL 35233-1711

  1. †

    Members of the Core Expert Panel: Timothy Beukelman, MD, MSCE, Randy Q. Cron, MD, PhD, Esi Morgan DeWitt, MD, MSCE, Norman T. Ilowite, MD, Yukiko Kimura, MD, Ronald M. Laxer, MDCM, FRCPC, Daniel J. Lovell, MD, MPH, Alberto Martini, MD, C. Egla Rabinovich, MD, MPH, Nicolino Ruperto, MD, MPH.

  2. ‡

    Members of the Task Force Panel: Suzanne L. Bowyer, MD (Indiana University School of Medicine, Indianapolis), Pavla Dolezalova, MD, PhD (Charles University, Prague, Czech Republic), Ciaran M. Duffy, MBBCh, MSc (McGill University, Montreal, Quebec, Canada), James P. Guevara, MD, MPH (Children's Hospital of Philadelphia, Philadelphia, PA), Anne Murphy, PhD (University of California, San Diego), Murray H. Passo, MD (Medical University of South Carolina, Charleston), Marilynn Punaro, MD (University of Texas Southwestern, Dallas), Rayfel Schneider, MBBCh, FRCPC (University of Toronto and Hospital for Sick Children, Toronto, Ontario, Canada), David D. Sherry, MD (Children's Hospital of Philadelphia, Philadelphia, PA), Earl D. Silverman, MD, FRCPC (University of Toronto and Hospital for Sick Children, Toronto, Ontario, Canada), Janalee Taylor, RN, MSN, CPNP (Cincinnati Children's Hospital Medical Center, Cincinnati, OH), Carol A. Wallace, MD (Seattle Children's Hospital Medical Center, Seattle, WA).

  3. §

    Members of the University of Alabama at Birmingham Working Group: Sheree Carter, RN, MSN, Jeffrey R. Curtis, MD, MPH, Archana Jain, MD, Amy Mudano, MPH, Pongthorn Narongroeknawin, MD.

  4. Members of the University of North Carolina at Chapel Hill Working Group: Rachel Fesperman, MD, MPH, Bethany Koestner, MSLS, Lynne Morris, MLS, Karen Rusak, MD, MPH.

  5. ‖

    American College of Rheumatology Board of Directors Liaison: Raphael Hirsch, MD (University of Pittsburgh, Pittsburgh, PA).

  6. ††

    The American College of Rheumatology is an independent professional, medical, and scientific society which does not guarantee, warrant, or endorse any commercial product or service.

  7. ‡‡

    Dr. Saag has received consultant fees, speaking fees, and/or honoraria (less than $10,000 each) from Merck, Lilly, Novartis, P&G, Aventis, Genentech, Takeda, AstraZeneca, and Horizon.

  8. §§

    Dr. Ilowite has received consultant fees, speaking fees, and/or honoraria (less than $10,000) from Genentech.

  9. ¶¶

    Dr. Kimura has served on the advisory board for Genentech and received a fee (less than $10,000).

  10. ‖‖

    Dr. Laxer is the Chair of the advisory board for Novartis and receives a fee (less than $10,000).

  11. †††

    Dr. Martini has received consultant fees, speaking fees, and/or honoraria (less than $10,000) from Bristol-Myers Squibb.

  12. ‡‡‡

    Dr. Ruperto has received consultant fees, speaking fees, and/or honoraria (less than $10,000 each) from Bristol-Myers Squibb, Roche, and Novartis.

Publication History

  1. Issue published online: 30 MAR 2011
  2. Article first published online: 30 MAR 2011
  3. Manuscript Accepted: 6 DEC 2010
  4. Manuscript Received: 29 JUN 2010

Funded by

  • American College of Rheumatology
  • University of Alabama at Birmingham Deep South Musculoskeletal Center for Education and Research on Therapeutics (Agency for Healthcare Research and Quality. Grant Number: U18-HS016956
  • NIH. Grant Number: 5KL2-RR025776-03
  • University of Alabama at Birmingham Center for Clinical and Translational Science

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS